CACHET B/C(redirected from Angiomax and Abciximab vs Heparin and Abciximab in PCI)
CACHET B/CA trial comparing the safety and efficacy of bivalirudin/Angiomax plus abciximab with heparin plus abciximab in patients undergoing PCI.
Bivalirudin ± provisional abciximab had fewer major adverse outcomes than heparin/abciximab.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.